Linfeng Ma

Dr. Linfeng Ma

clinical laboratory, Yuhuangding Hospital, Yantai, Shandong, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
JZJingkai Zhou
Jingkai Zhou
TZTiangang Zhao
Tiangang Zhao
LMLinfeng Ma
Linfeng Ma
MLMin Liang
Min Liang
YGYing-Jie Guo
Ying-Jie Guo
LZLi-Mei Zhao
Li-Mei Zhao
Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling

17 November 2022 in Engineering Failure Analysis
Verified
Journal Article
Closed access
LHLu He
Lu He
DWDi Wu
Di Wu
LMLinfeng Ma
Linfeng Ma

1 December 2020 in Toxicology
Verified
Journal Article
Closed access
LMLinfeng Ma
Linfeng Ma
YWYani Wang
Yani Wang
XCXue Chen
Xue Chen
LZLimei Zhao
Limei Zhao
YGYingjie Guo
Yingjie Guo

1 February 2019 in Therapeutic Drug Monitoring
Verified
Journal Article
Closed access
LMLinfeng Ma
Linfeng Ma
YPYue Pan
Yue Pan
MSMing Sun
Ming Sun
HSHaonan Shen
Haonan Shen
LZLimei Zhao
Limei Zhao
YGYingjie Guo
Yingjie Guo
Background: Individual susceptibility to valproic acid (VPA)-caused hepatotoxicity might result from genetic deficiencies in the detoxification and antioxidant enzymes including glutathione S-transferases (GSTs), catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx). This study aimed to investigate the relationships between GST mu 1 ( GSTM1 ), GST theta 1 ( GSTT1 ), CAT C-262T, GPx1 Pro200Leu, and SOD2 Val16Ala polymorphisms and the risk of abnormal liver function in Chinese epileptic patients treated with VPA monotherapy. Methods: According to the levels of liver function indicators, a total of 267 epileptic patients between 1 and 65 years of age were divided into normal liver function group and abnormal liver function group. GSTM1 and GSTT1 polymorphisms were determined using polymerase chain reaction (PCR) amplification based on the absence of a PCR amplification product. CAT , GPx1 , and SOD2 polymorphisms were identified using PCR-restriction fragment length polymorphism or direct automated DNA sequencing. Results: Carriers of CAT had an increased risk of developing abnormal liver function compared with noncarriers in VPA-treated patients (odds ratio 3.968, P = 0.003). Logistic regression analyses indicated that the CAT genotype was a significant genetic risk factor for VPA-induced liver dysfunction. It suggests that individual susceptibility to VPA-induced liver dysfunction may at least partially result from genetic deficiencies in CAT C-262T.

1 November 2019 in Optical Materials
Verified
Journal Article
Closed access
YZYuhui Zhang
Yuhui Zhang
LMLinfeng Ma
Linfeng Ma
Zhiying LiuZhiying Liu
Zhiying Liu
YFYuegang Fu
Yuegang Fu

23 February 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
JZJingwei Zhu
Jingwei Zhu
ZWZhe Wang
Zhe Wang
XSXiaotong Sun
Xiaotong Sun
DWDan Wang
Dan Wang
XXXinbo Xu
Xinbo Xu
LMLinfeng Ma
Linfeng Ma
Valproic acid (VPA) has been widely used as an antiepileptic drug for decades. Although VPA is effective and well-tolerated, long-term VPA treatment is usually associated with hepatotoxicity. However, the underlying mechanisms of VPA-caused hepatotoxicity remain unclear. In this study, a total of 157 pediatric patients with epilepsy were recruited and divided into normal liver function (NLF, 112 subjects) group and abnormal liver function (ABLF, 45 subjects) group. We observed that MTHFR A1298C and MTHFR C677T variants may be linked to VPA-induced liver dysfunction (p = 0.001; p = 0.023, respectively). We also found that the MTHFR A1298C polymorphism was associated with a higher serum Hcy level (p = 0.001) and a lower FA level (p = 0.001). Moreover, the serum Hcy levels was strongly correlated with the GSH and TBARS concentrations (r = −0.6065, P < 0.001; r = 0.6564, P < 0.001, respectively). Furthermore, logistic analysis indicated that MTHFR A1298C/C677T polymorphisms and increased Hcy concentrations may be risk factors for VPA-induced liver dysfunction. These results suggested that individual susceptibility to VPA-induced liver dysfunction may result from MTHFR A1298C/C677T polymorphisms and increased Hcy levels. This study may be helpful for the prevention and guidance of VPA-induced liver dysfunction.